Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Top Pharmaceutical Stocks To Consider - December 16th
32,205 Shares in AbbVie Inc. $ABBV Purchased by Shorepoint Capital Partners LLC
Park National Corp OH Decreases Stock Holdings in AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Shares Purchased by GAMMA Investing LLC
Corient Private Wealth LLC Boosts Stock Position in AbbVie Inc. $ABBV
St. Louis Financial Planners Asset Management LLC Takes $3.39 Million Position in AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Stock Price Up 1.9% - Time to Buy?
AbbVie (NYSE:ABBV) Shares Up 1.9% - What's Next?
Promising Pharmaceutical Stocks To Watch Now - December 15th - Markets Daily
Stance Capital LLC Takes $1.26 Million Position in AbbVie Inc. $ABBV
5,914 Shares in AbbVie Inc. $ABBV Purchased by Marex Group plc - Markets Daily
Rep. Julie Johnson Sells Off Shares of AbbVie Inc. (NYSE:ABBV)
3 US Dividend Stocks Every Singapore Investor Should Know
AbbVie Inc. $ABBV Shares Acquired by Geneos Wealth Management Inc.
Caldwell Trust Co Takes Position in AbbVie Inc. $ABBV
American Trust Has $4.43 Million Stock Holdings in AbbVie Inc. $ABBV
Valeo Financial Advisors LLC Sells 29,989 Shares of AbbVie Inc. $ABBV - Daily Political
Marex Group plc Acquires Shares of 5,914 AbbVie Inc. $ABBV - Stock Observer
Public Sector Pension Investment Board Sells 25,601 Shares of AbbVie Inc. $ABBV - Markets Daily
Pitcairn Co. Sells 3,342 Shares of AbbVie Inc. $ABBV - Markets Daily
Advisory Services Network LLC Grows Position in AbbVie Inc. $ABBV
Pitcairn Co. Decreases Stock Position in AbbVie Inc. $ABBV - Stock Observer
Kentucky Retirement Systems Sells 7,443 Shares of AbbVie Inc. $ABBV - Daily Political
How AbbVie's Capital-Light ABBV-230 Deal Reshape At AbbVie (ABBV) Has Changed Its Investment Story
Assessing AbbVie (ABBV) Valuation After HSBC Upgrade, Strong Earnings, and Dividend Hike
AbbVie Inc. $ABBV Shares Acquired by Curi Capital LLC - Markets Daily
AbbVie Inc. $ABBV Shares Acquired by BI Asset Management Fondsmaeglerselskab A S
Pharmaceutical Stocks To Follow Today - December 10th - Stock Observer
Ameriprise Financial Inc. Sells 3,127,890 Shares of AbbVie Inc. $ABBV
Adage Capital Partners GP L.L.C. Lowers Position in AbbVie Inc. $ABBV
Engineers Gate Manager LP Increases Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Raised to Strong-Buy at Wall Street Zen
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 59,257 Shares of AbbVie Inc. $ABBV - Daily Political
BBR Partners LLC Sells 4,280 Shares of AbbVie Inc. $ABBV - Daily Political
Bellevue Group AG Boosts Stock Position in AbbVie Inc. $ABBV - Daily Political
Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases
Peapack Gladstone Financial Corp Buys 20,164 Shares of AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Shares Bought by Quantinno Capital Management LP
Hamilton Capital LLC Cuts Holdings in AbbVie Inc. $ABBV
Alliancebernstein L.P. Increases Stake in AbbVie Inc. $ABBV
Peapack Gladstone Financial Corp Acquires 20,164 Shares of AbbVie Inc. $ABBV - Stock Observer
Diversify Advisory Services LLC Buys 10,883 Shares of AbbVie Inc. $ABBV - Daily Political
Why AbbVie, Pfizer and Medtronic appeal to dividend investors
CIBC Asset Management Inc Has $59.11 Million Stock Holdings in AbbVie Inc. $ABBV - Markets Daily
The Manufacturers Life Insurance Company Grows Stock Position in AbbVie Inc. $ABBV - Stock Observer
HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265
AbbVie (NYSE:ABBV) Raised to "Strong-Buy" at Hsbc Global Res - Daily Political
This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence
HSBC highlights one pharma stock to buy and one to sell for 2026
AbbVie Inc. $ABBV Shares Sold by Integrated Investment Consultants LLC
Gamco Investors INC. ET AL Grows Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
NewEdge Advisors LLC Has $103.13 Million Stake in AbbVie Inc. $ABBV - Daily Political
Botox brand struggles amid natural aging movement
Medincell Publishes its Consolidated Half-Year Financial Results
AbbVie Inc. $ABBV Shares Bought by State Street Corp
Daiwa Securities Group Inc. Buys 38,862 Shares of AbbVie Inc. $ABBV
Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029
Tripletail Wealth Management LLC Acquires New Holdings in AbbVie Inc. $ABBV - Daily Political
Certuity LLC Sells 2,442 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Shares Down 1.4% - Here's Why
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT) | Taiwan News | Dec. 9, 2025 05:30
SVB Wealth LLC Sells 113,330 Shares of AbbVie Inc. $ABBV
Ossiam Has $51.75 Million Holdings in AbbVie Inc. $ABBV
Gabelli Funds LLC Cuts Stock Holdings in AbbVie Inc. $ABBV
AbbVie Inc. (NYSE:ABBV) Receives $241.85 Consensus Price Target from Analysts - Markets Daily
Jump Financial LLC Buys New Shares in AbbVie Inc. $ABBV - Stock Observer
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development | Taiwan News | Dec. 8, 2025 14:30
Ossiam Acquires 230,317 Shares of AbbVie Inc. $ABBV - Daily Political
ABBV: Future Performance Will Depend On Extended Exclusivity And Pipeline Execution
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
Federated Hermes Inc. Acquires 134,942 Shares of AbbVie Inc. $ABBV
Cerity Partners LLC Has $210.15 Million Holdings in AbbVie Inc. $ABBV
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) | Taiwan News | Dec. 6, 2025 22:30
SageView Advisory Group LLC Increases Stock Position in AbbVie Inc. $ABBV - Markets Daily
SageView Advisory Group LLC Acquires 4,020 Shares of AbbVie Inc. $ABBV - Stock Observer
Is AbbVie's Expanding Migraine And Oncology Pipeline Reshaping The Investment Case For AbbVie (ABBV)?
StoneX Group Inc. Has $8.75 Million Stake in AbbVie Inc. $ABBV - Daily Political
Brokerages Set AbbVie Inc. (NYSE:ABBV) Target Price at $241.85 - Stock Observer
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) | Valuespectrum.com
AbbVie (NYSE:ABBV) Shares Down 1.1% - What's Next?
Marshall Wace LLP Grows Stake in AbbVie Inc. $ABBV
M Holdings Securities Inc. Increases Holdings in AbbVie Inc. $ABBV
Quantbot Technologies LP Takes Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Position Lifted by Epoch Investment Partners Inc.
AbbVie Inc. $ABBV Shares Purchased by Cresset Asset Management LLC - Daily Political
Kennedy Capital Management LLC Reduces Holdings in AbbVie Inc. $ABBV
First Trust Advisors LP Trims Stake in AbbVie Inc. $ABBV
Groupe la Francaise Purchases 6,466 Shares of AbbVie Inc. $ABBV
Baird Financial Group Inc. Sells 36,202 Shares of AbbVie Inc. $ABBV
Kennedy Capital Management LLC Lowers Stake in AbbVie Inc. $ABBV - Stock Observer
Best Pharmaceutical Stocks To Keep An Eye On - December 1st - Stock Observer
Assessing AbbVie's (ABBV) Valuation After New Cancer Data, EPKINLY Approval, and Dividend Hike
